Inventor · Milpitas, CA, US

Karla A. HENNING

22Patents
7h-index
49Co-inventors
61Inventor score

Filing activity: Nov 12, 2014 → Jul 21, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9228016B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 31 Active
US9683998B2 Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof Chemistry; Metallurgy 21 Active
US9605080B2 Antibodies against CD73 Physics 19 Active
US10100129B2 Antibodies against CD73 and uses thereof Physics 13 Active
US9745379B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 11 Active
US10501550B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 7 Active
US10653791B2 Antibodies comprising modified heavy constant regions Chemistry; Metallurgy 7 Active
US10465010B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 7 Active
US10690674B2 Anti-GITR antibodies for cancer diagnostics Physics 5 Active
US11213586B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) Chemistry; Metallurgy 4 Active
US11084881B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 3 Active
US10167343B2 Antibodies against CD73 Physics 3 Active
US11408889B2 Anti-GITR antibodies for cancer diagnostics Physics 1 Active
US11274150B2 Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies Emerging Cross-Sectional Technologies 0 Active
US11753474B2 Anti-Dectin-2 antibodies Chemistry; Metallurgy 0 Active
US11352440B2 Antibodies against CD73 and uses thereof Physics 0 Active
US12325750B2 Anti-Dectin-2 antibodies and methods of using Chemistry; Metallurgy 0 Active
US11802162B2 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Physics 0 Active
US11474112B2 Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof Chemistry; Metallurgy 0 Active
US12372536B2 Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof Chemistry; Metallurgy 0 Active
US12077584B2 Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) Emerging Cross-Sectional Technologies 0 Active
US11981734B2 Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.